HOUGHTEN PHARM INC has a total of 28 patent applications. Its first patent ever was published in 1993. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BHATNAGAR RAKESH, ACCELERON PHARMA INC and MODIGENE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | United States | 5 | |
#3 | Australia | 3 | |
#4 | Norway | 3 | |
#5 | Canada | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Finland | 2 | |
#8 | China | 1 | |
#9 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Houghten Richard A | 22 |
#2 | Girten Beverly E | 15 |
#3 | Tuttle Ronald R | 14 |
#4 | Loullis Costas C | 11 |
#5 | Suto Mark J | 11 |
#6 | Omholt Paul | 8 |
#7 | Weber Patricia A | 8 |
#8 | Basu Amaresh | 6 |
#9 | Andablibi Ali | 5 |
#10 | Fagan Patrick | 5 |
Publication | Filing date | Title |
---|---|---|
US5578573A | Viral integrase inhibiting peptides | |
US5480971A | Peralkylated oligopeptide mixtures | |
US5441936A | Antiviral peptides | |
US5420109A | Cytokine restraining agents | |
US5367053A | Opioid peptide inhibitors |